Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v2-EN
Language French English
Date Updated 2020-05-29 2017-03-23
Drug Identification Number 02382067 02382067
Brand name ALLERJECT ALLERJECT
Common or Proper name EPINEPHRINE SOLUTION FOR INJECTION USP EPINEPHRINE SOLUTION FOR INJECTION USP 1:1000
Company Name VALEO PHARMA INC VALEO PHARMA INC
Ingredients EPINEPHRINE EPINEPHRINE
Strength(s) 0.3MG 0.3MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 UNITS/1 CARTON 2 UNITS/1 CARTON
ATC code C01CA C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-03-23 2017-03-23
Actual start date 2017-03-23 2017-03-23
Estimated end date Unknown Unknown
Actual end date 2020-05-19
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments